SPRO
SPRO clinical trials: Spero Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Spero Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 24
- Trials linked
- 22
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SPRO on the catalyst calendar · SPRO registry changes
- Primary completion Jan 27, 2025ActualPhase 3NCT06059846A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated...Spero Therapeutics · Urinary Tract InfectionCompletedSPROLeadGSKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 8, 2024ActualPhase 2NCT05496374A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of...Spero Therapeutics · Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)CompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 22, 2025ActualPhase 1NCT06727136A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite...Spero Therapeutics · Healthy ParticipantsCompletedSPROLeadGSKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2021ActualPhase 1NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal FunctionSpero Therapeutics · Renal ImpairmentCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2023ActualPhase 1NCT05856747A Study to Compare Two Bioanalytical Assays for TebipenemSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 9, 2024ActualPhase 1NCT05955586A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar...Spero Therapeutics · Healthy VolunteerCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 30, 2024ActualPhase 1NCT05966688A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy ParticipantsSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 20, 2020ActualPhase 3NCT03788967Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to...Spero Therapeutics · Complicated Urinary Tract InfectionCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 28, 2021ActualPhase 2NCT04553406Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC)...Spero Therapeutics · Mycobacterium Avium ComplexTerminatedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 16, 2021ActualPhase 1NCT04868292Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy VolunteersSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 6, 2021ActualPhase 1NCT04376554Effect of Tebipenem on Normal Human Intestinal MicrobiotaSpero Therapeutics · Healthy VolunteersCompletedSPROLeadIQVCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2021ActualPhase 1NCT04710407Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar...Spero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2020ActualPhase 1NCT04178577Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal FunctionSpero Therapeutics · Renal ImpairmentCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 16, 2020ActualPhase 1NCT04625855Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in...Spero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 8, 2020ActualPhase 1NCT04368585Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide...Spero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 11, 2020ActualPhase 1NCT04421885Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult SubjectsSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2020ActualPhase 1NCT04238195A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil...Spero Therapeutics · TQT StudyCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2019ActualPhase 1NCT03792308A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy VolunteersSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 24, 2019ActualPhase 1NCT03796910A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy VolunteersSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2, 2018ActualPhase 1NCT03395249Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994Spero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2017ActualPhase 1NCT03376529Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741Spero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2017ActualPhase 1NCT03022175A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy VolunteersSpero Therapeutics · Healthy VolunteersCompletedSPROLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2022ActualPhase 1NCT05296382Bioavailability of Tebipenem (SPR994) Crushed TabletHartford Hospital · Relative BioavailabilityCompletedSPROCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2022ActualPhase 1NCT04919954Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisHartford Hospital · DiabetesCompletedSPROCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 24 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner